Famciclovir

This classification denotes a purine antagonist and antiviral agent with the molecular formula C14H19N5O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QIC03ANI02, chemically known as 1,3-propanediol, 2-(2-(2-amino-9h-purin-9-yl)ethyl)-, diacetate (ester) but generally known as famciclovir, which bears US NIH Compound Identifier 3324. European Medicines Agency schedules Famciclovir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07501MIG. The term FAMCICLOVIR is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). World Health Organization schedules famciclovir in its Anatomical Therapeutic Chemical (ATC) Classification. FAMCICLOVIR is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule famciclovir under HS 29335995 and SITC 51576. As of Q4 2014, FAMCICLOVIR remains the US FDA Preferred Term for this commodity. Famciclovir bears US NLM identifiers UMLS ID C0209227 and NCI Concept Code C29044. SMILES: O(CC(CCN1C2NC(NCC2NC1)N)COC(=O)C)C(=O)C.